PD22-10 HIGH VOLUME BIOPSY CORE INVOLVEMENT PREDICTS FOR ELEVATED PSA NADIR FOLLOWING DEFINITIVE SBRT IN INTERMEDIATE RISK PROSTATE CANCER. (May 2022)